{"resourceType":"Bundle","id":"tests-1994e69a-472b-4e32-80c1-5c692f36acce-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/1994e69a-472b-4e32-80c1-5c692f36acce","resource":{"resourceType":"Patient","id":"1994e69a-472b-4e32-80c1-5c692f36acce","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><div class=\"hapiHeaderText\">Opioid exactly 12 hrs before Naloxone <b>NUMERPASS </b></div><table class=\"hapiPropertyTable\"><tbody><tr><td>Date of birth</td><td><span>14 November 1980</span></td></tr></tbody></table></div>"},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"627a80a15a0d870123c7253e"}],"active":true,"name":[{"use":"usual","family":"NUMERPass","given":["OpioidExactly12hrsBeforeAntagonist"]}],"gender":"female","birthDate":"1980-11-14"},"request":{"method":"PUT","url":"Patient/1994e69a-472b-4e32-80c1-5c692f36acce"}},{"fullUrl":"https://madie.cms.gov/Encounter/5f32cfdc97c3b600003f7c9c","resource":{"resourceType":"Encounter","id":"c4731e87-162d-41bb-94d2-1501434b7fc7","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter"]},"status":"finished","class":{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","code":"IMP","display":"inpatient encounter"},"type":[{"coding":[{"system":"http://snomed.info/sct","code":"183452005"}]}],"subject":{"reference":"Patient/1994e69a-472b-4e32-80c1-5c692f36acce"},"period":{"start":"2025-08-11T08:00:00.000Z","end":"2025-08-14T08:15:00.000Z"}},"request":{"method":"PUT","url":"Encounter/c4731e87-162d-41bb-94d2-1501434b7fc7"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/5f32cff097c3b600003f7cb9","resource":{"resourceType":"MedicationAdministration","id":"7662d008-e288-4e4b-aad2-b27f25c76adf","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600"}]},"subject":{"reference":"Patient/1994e69a-472b-4e32-80c1-5c692f36acce"},"effectivePeriod":{"start":"2025-08-11T08:00:00.000Z","end":"2025-08-11T08:15:00.000Z"}},"request":{"method":"PUT","url":"MedicationAdministration/7662d008-e288-4e4b-aad2-b27f25c76adf"}},{"fullUrl":"https://madie.cms.gov/MedicationAdministration/5f32d03297c3b600003f7cd9","resource":{"resourceType":"MedicationAdministration","id":"0b2eb07a-3ae5-44fc-b9ca-749657bdcff2","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration"]},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2022-04","code":"1659929","display":"1 ML naloxone hydrochloride 0.4 MG/ML Injection","userSelected":true}]},"subject":{"reference":"Patient/1994e69a-472b-4e32-80c1-5c692f36acce"},"effectivePeriod":{"start":"2025-08-11T20:15:00.000+00:00"},"dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"34206005","display":"Subcutaneous route (qualifier value)","userSelected":true}]},"dose":{"value":0.4,"unit":"mg","system":"http://unitsofmeasure.org","code":"mg"}}},"request":{"method":"PUT","url":"MedicationAdministration/0b2eb07a-3ae5-44fc-b9ca-749657bdcff2"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/fc088acb-093c-4e36-b8d4-7ae4d9d198cb","resource":{"resourceType":"MeasureReport","id":"fc088acb-093c-4e36-b8d4-7ae4d9d198cb","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"a1ca3a6d-bcac-49da-b72c-35a6ab1f0e60-parameters","parameter":[{"name":"subject","valueString":"1994e69a-472b-4e32-80c1-5c692f36acce"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#a1ca3a6d-bcac-49da-b72c-35a6ab1f0e60-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Inpatient encounter where patient given opioid 8:15AM. Antagonist administration start time is 8:15PM, exactly 12 hours after opioid. Meets numerator criteria. "}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/HospitalHarmOpioidRelatedAdverseEventsFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":1}]}]},"request":{"method":"PUT","url":"MeasureReport/fc088acb-093c-4e36-b8d4-7ae4d9d198cb"}}]}